P890017S001

None

FDA Premarket Approval P890017 S001

This post-approval study has not been publically released by the fda. It may be a place-holder supplement number.

Pre-market Approval Supplement Details

DeviceP890017S001
Classification NameNone
Applicant
PMAP890017
SupplementS001

Supplemental Filings

Supplement NumberDateSupplement Type
P890017Original Filing
S023 2022-09-28 Real-time Process
S022 2021-12-08 Real-time Process
S021
S020 2019-07-23 30-day Notice
S019 2016-11-01 30-day Notice
S018 2016-03-01 135 Review Track For 30-day Notice
S017 2015-06-24 135 Review Track For 30-day Notice
S016 2015-03-17 30-day Notice
S015 2009-10-01 30-day Notice
S014 2006-01-20 Real-time Process
S013
S012
S011 2003-04-15 Normal 180 Day Track
S010 2001-12-06 Panel Track
S009 2000-05-26 Special (immediate Track)
S008 2000-03-23 Normal 180 Day Track
S007 1999-07-16 Normal 180 Day Track
S006 1998-12-31 Normal 180 Day Track
S005 1998-09-02 30-day Notice
S004 1994-02-22 Normal 180 Day Track
S003
S002 1992-04-06 Normal 180 Day Track
S001

NIH GUDID Devices

Device IDPMASupp
20705032057292 P890017 015
20705032057346 P890017 015
20705032057247 P890017 015
20705032057223 P890017 015
20705032057261 P890017 015
20705032057285 P890017 015
20705032057315 P890017 015

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.